CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 54 filers reported holding CYCLERION THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $256,971 | +66645.7% | 592,237 | +0.9% | 0.00% | – |
| Q4 2022 | $385 | -99.9% | 586,737 | +0.5% | 0.00% | – |
| Q3 2022 | $502,000 | +59.9% | 583,819 | +1.8% | 0.00% | – |
| Q2 2022 | $314,000 | -51.5% | 573,694 | -1.7% | 0.00% | – |
| Q1 2022 | $647,000 | -33.5% | 583,383 | +3.1% | 0.00% | – |
| Q4 2021 | $973,000 | -35.4% | 565,835 | +15.3% | 0.00% | – |
| Q3 2021 | $1,506,000 | +0.4% | 490,660 | +27.5% | 0.00% | – |
| Q2 2021 | $1,500,000 | +10.5% | 384,820 | -21.0% | 0.00% | – |
| Q1 2021 | $1,358,000 | +2.3% | 486,959 | +12.2% | 0.00% | – |
| Q4 2020 | $1,327,000 | -38.2% | 433,862 | +22.9% | 0.00% | – |
| Q3 2020 | $2,146,000 | +14.9% | 352,971 | +11.6% | 0.00% | – |
| Q2 2020 | $1,868,000 | +118.5% | 316,153 | -2.1% | 0.00% | – |
| Q1 2020 | $855,000 | -47.7% | 323,002 | -46.2% | 0.00% | – |
| Q4 2019 | $1,634,000 | -45.1% | 600,746 | +144.3% | 0.00% | -100.0% |
| Q3 2019 | $2,979,000 | +7.8% | 245,873 | +1.8% | 0.00% | 0.0% |
| Q2 2019 | $2,764,000 | – | 241,446 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $3,105,683 | 0.15% |
| Artal Group S.A. | 2,779,122 | $1,206 | 0.07% |
| MFN Partners Management, LP | 3,389,215 | $1,470,580 | 0.07% |
| Intrinsic Value Partners, LLC | 43,105 | $18,703 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $49,899 | 0.00% |
| Penobscot Investment Management Company, Inc. | 10,000 | $4,339 | 0.00% |
| COLONY GROUP LLC | 102,884 | $44 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 292,645 | $126,979 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 592,237 | $256,971 | 0.00% |
| STATE STREET CORP | 115,414 | $50,078 | 0.00% |